05-Aug-2014, Spontaneous, Patient/Consumer Serious report (Sanofi Aventis 1-579557594).
An Unknown-old Male patient reported he received COPAXONE (GLATIRAMER ACETATE, Product is or cannot 
be excluded as a Teva product). 
The patient took COPAXONE (GLATIRAMER ACETATE, Dosage information not provided).
While on the suspect medication(s), the patient experienced INJECTION SITE REACTION(Not Serious ); SICK 
DAILY(Not Serious ); JC VIRUS(Serious ); STOMACH ISSUES(Not Serious ); APPENDIX REMOVED(Serious ); 
ULCER(Not Serious ); ELBOW LOCKED(Not Serious , since -Aug-2013); RA(Serious ); POOR EYE HAND 
COORDINATION(Not Serious ) . 
"Patient diagnosed 2008.  Started on Avonex for 1 year - stoppped due to "reactions made me sick."  Switched to 
Copaxone.  Was on Copaxone for six months.  Stopped due to injections ite reaction.  Switched to Rebif for a few 
months.  Stopped due to sick daily. Started Betaseron for about three doses.  Then back to Avonex for 2-3 weeks.
Patient then switched to Tysabri for three years.  Stopped due to positive for JC virus although risk was low.
Switched to Tecfidera for 2 1/2 months.  Stopped due to stomach issues.  Was also on Methotrexate with 
Tecfidera.  Has had appendix removed and has an ulcer.  Aug-2013 patient work up in August and elbow was 
locked.  Diagnsed with rheumatoid arthritis.  Patient has poor eye hand coordination."  Additional information has 
been requested.
At the time of the report the outcome of the AEs were:   JC VIRUS : Unknown,   RA : Unknown,   APPENDIX 
REMOVED : Unknown,   ULCER : Unknown,   STOMACH ISSUES : Unknown,   SICK DAILY : Unknown,   ELBOW
LOCKED : Unknown,   POOR EYE HAND COORDINATION : Unknown,   INJECTION SITE REACTION : 
Unknown.
Action taken with suspect drugs: COPAXONE due to SICK DAILY, JC VIRUS, STOMACH ISSUES, APPENDIX 
REMOVED, ULCER, ELBOW LOCKED, RA, POOR EYE HAND COORDINATION - Not applicable; COPAXONE 
due to INJECTION SITE REACTION - Drug discontinued.
The patient had medical history of REACTIONS TO AVONEX MADE SICK(Not Continuing).
The patient's concomitant medication were unspecified.
The patient's past medication included INTERFERON BETA
Lab tests were not reported.
This case was considered serious based on the following criteria: (Other Serious (Important Medical Events))
Teva Comment:  GLATIRAMER ACETATE: Injection site reaction has been reported in association with the use of 
Print Time: 24-MAY-2016 07:56 AM If a field is blank, there is no data for that field Page 171 of 570
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
Copaxone. Rheumatoid arthritis, appendectomy, and ulcer, are intercurrent medical illnesses. The other reported 
events are more likely associated with the use of the other medications the patient was on at the time of the event. 
Causality: Injection site reaction - Possibly related to Copaxone; All other reported events - Not Related to 
Copaxone.
Because this is a spontaneous case, regulatory distribution will be handled as though it is a related case.
9-Sep-2014:
Follow up information recevied from the consumer: Patient left voicemail (VM) on 04Sep2014 asking for a call back 
regarding letter he received. No other info provided at this time. I left a vm for patient on 04-Sep-2014- no 
response. I called patient again on 09Sep2014 and spoke live. Patient stated that he was not on Copaxone at time 
of JC Virus. No other info provided.
Teva comment:  No change in causality.